🇺🇸 FDA
Patent

US 11821008

Liver targeting adeno-associated viral vectors

granted A61KA61K35/761A61K48/0025

Quick answer

US patent 11821008 (Liver targeting adeno-associated viral vectors) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K35/761, A61K48/0025, A61P, A61P1/16